Evidence map›Paper›PMID 32564611›Full record

ArticleFuture oncology (London, England)2020

A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer?

Emre Yekedüz, Ayşe Müge Karcıoğlu, Güngör Utkan, Yüksel Ürün

Abstract readEditorial
In one paragraph

Article in Future oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  2. Endobronchial histoplasmosis mimicking primary bronchogenic carcinoma during the COVID-19 pandemic.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2022
    Article
  3. Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.International journal of environmental research and public health · 2021
    Observational
  4. "Swords and Shields" against COVID-19 for patients with cancer at "clean" and "pandemic" hospitals: are we ready for the second wave?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  5. Article
  6. Cancer treatment in the coronavirus disease pandemic.Lung cancer (Amsterdam, Netherlands) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emre YekedüzAnkara University Faculty of Medicine Department of Medical Oncology, Ankara, Turkey.ORCID https://orcid.org/0000-0001-6819-5930
Ayşe Müge KarcıoğluDepartment of Intensive Care, Ministry of Health Ankara City Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0002-2154-7975
Güngör UtkanAnkara University Faculty of Medicine Department of Medical Oncology, Ankara, Turkey.ORCID https://orcid.org/0000-0001-8445-6993
Yüksel ÜrünAnkara University Faculty of Medicine Department of Medical Oncology, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9152-9887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Incidental FindingsBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingEarly Detection of CancerHumansInfection ControlLungLung NeoplasmsMass ScreeningPandemicsPneumonia, ViralSARS-CoV-2Tomography, X-Ray ComputedCOVID-19incidental cancer diagnosismissed cancer diagnosis

Identifiers

PMID32564611
PMCPMC7307743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.